New Fast PCR Tests are Quicker than Self Diagnosis Kits
Researchers have developed an ultrafast PCR technology that shortens test time by 10-fold, compared with time taken for the existing test.
Researchers have developed an ultrafast PCR technology that shortens test time by 10-fold, compared with time taken for the existing test.
COVID-19’s lockdowns in the UK left over a million people with diabetes without access to the routine HbA1C blood testing needed to manage their diabetes.
The acquisition is expected to streamline the commercialization of the company's Eikon platform and YourTest PCR device as it nears completion.
Researchers have made progress toward a new diagnostic test for schistosomiasis which could help achieve interrupting transmission of the disease.
Read MoreEssenlix Corporation, in partnership with Roche Norway, has won Norway Østfold Hospital System’s “Patient At-Home Test” Innovation Partnership.
Read MoreA month after its October deadline, Los Angeles’ unvaccinated city workers are still not being tested for COVID-19.
Read MoreEllume has recalled its COVID-19 Home Test for potential false-positive results. The FDA has listed this recall as Class 1, it’s most serious category.
Read MoreThe FDA has issued guidelines aimed at increasing access to accurate and reliable COVID-19 tests, particularly those that can be performed at home.
Read MoreA research team from Georgia Tech has developed flow control technology to turn simple lateral flow assays into complex biomedical assays.
Read MoreThe Tech Guide from the September 2021 issue of Clinical Lab Products includes point-of-care assays and analyzers from 17 suppliers.
Read MoreVisby Medical has received a 510(k) clearance to market its fast, single-use PCR diagnostic test for the detection of STIs.
Read MoreIn screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Read MoreThe product is a molecular nucleic acid amplification test that is intended to detect genetic material from SARS-CoV-2 virus present in the nostrils.
Read MorePatients can order Adaptive Biotechnologies’ T-Detect Covid online, have blood drawn at LabCorp locations or via mobile phlebotomists at their homes, and receive results via an online portal.
Read MoreThe self-administered, noninvasive saliva kits are FDA authorized for use by both individuals with and without symptoms of covid-19.
Read MoreQuest Diagnostics RC Covid-19 +Flu RT-PCR Test with the Quest Diagnostics Self-Collection Kit for Covid-19 +Flu is for prescription use by individuals who are suspected of respiratory viral infection consistent with covid-19.
Read MoreThe Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read MoreThe FDA CLIA-waived handheld analyzer reliably and efficiently delivers results within just 5 to 10 seconds, and it can be used in point-of-care (POC) and certificate of waiver settings, such as physicians’ offices, clinics, and other nontraditional laboratory locations.
Read More